Ehave Announces Plans to Expand its Health Informatics Technology into Veterinary Medicine

Thursday, November 16, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+

Company to License Core Informatics Platform to Companion Healthcare Technologies, Inc.

TORONTO, Nov. 16, 2017

/PRNewswire/ -- Ehave, Inc. (OTCQB: EHVVF), a healthcare company dedicated to empowering the mental health community with next-generation digital solutions, today announced plans to expand its business into veterinary medicine.  The company has executed
a Letter of Intent (LOI) whereby Companion Healthcare Technologies, Inc. (CHT), a company engaged in partnering, licensing and incubating cutting edge healthcare technologies to improve the quality of care for pets, will license Ehave's core health informatics platform for animal health.  In the U.S., 68% of households have pets and the national spend on these companion animals continues to grow exponentially.  It is estimated at approximately $70 billion for 2017.

"The veterinary healthcare market continues to undergo explosive growth marked by a drive for new medicines, diagnostics, and technologies that can elevate the quality and access to care for companion animals," said Prateek Dwivedi, CEO of Ehave. "This expansion into yet another emerging healthcare vertical exemplifies the versatility and utility of our technology and is in line with our efforts to fully leverage the flexibility of our core health informatics platform in areas where there is an opportunity to add immediate value and revenue.  As the pace of innovation in animal health continues to accelerate, our platform is ideally designed to support the growth of this exciting industry.  Similar to our established applications in mental health and medical cannabis, by licensing our core platform, CHT and its partners in veterinary research and clinical practice will be able to more effectively monitor, utilize, and improve therapeutic outcomes for pets by capturing and analyzing real-time, objective patient data."

Under the proposed license agreement, CHT will have exclusive rights to Ehave's informatics platform for use, in any indication, in companion animals.  CHT will seek to integrate Ehave's platform across the entire companion animal clinical pathway and related developments in the acceleration of quality of healthcare; allowing for consistent, consolidated data acquisition and analysis.

About Ehave, Inc.Ehave is empowering the mental healthcare community with a next-generation of data-rich tools designed to improve patient management, diagnosis and treatment. With Ehave Connect, Ehave's mental health informatics platform, clinicians can make objective, data-driven decisions while keeping patients informed and engaged throughout their mental healthcare journey. Ehave Connect offers a powerful set of core features that integrate with a growing selection of tools and applications developed by Ehave and its leading partners, including Multi-Health Systems ("MHS"), a leading publisher of psychological assessments. Ehave is initially focused on improving the standard of care in attention deficit hyperactivity disorder ("ADHD"), through its collaboration with the Hospital for Sick Children ("SickKids"). Ehave Connect is also being utilized to advance the validation and optimization of medical cannabis, through its collaboration with MedReleaf. For more information, visit

About Companion Healthcare Technologies, Inc.Companion Healthcare Technologies, Inc. ["CHT"] is a private company engaged in partnering, licensing and incubating healthcare technologies with direct value to veterinary patients to improve the quality of care of companion animals and to improve treatment outcomes.  CHT, along with its partner organizations, work closely with human healthcare companies and institutions to access cutting edge diagnostic and therapeutic products for translation to companion animal care. 

Ehave Contacts

Tiberend Strategic Advisors, Inc. Joshua Drumm, Ph.D. (Investors)(212) 375-2664

Janine McCargo (Media)646-604-5150

View original content:

SOURCE Ehave, Inc.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store